Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Retatrutide (LY3437943) is a research peptide investigated for interaction with GLP-1, GIP, and glucagon receptor systems
If you anticipate an extended break from treatment due to illness, surgery, or other circumstances, discuss this with your healthcare provider in advance
Ozempic may also lower your risk of cannabis use disorder
Administration Routes in Research Multiple delivery methods have been investigated for component peptides: Subcutaneous injection Most common route for combined formulations in research settings Intraperitoneal injection Used in systemic studies, particularly effective for BPC-157 Intramuscular injection Applied in musculoskeletal research protocols Oral administration Uniquely effective for BPC-157 and KPV components unlike most peptides Local/topical application Used in wound healing and dermatological studies Transdermal delivery KPV demonstrated enhanced delivery with iontophoresis and microneedles Intravenous injection Primarily for pharmacokinetic characterization The combination of BPC-157 and KPVs oral bioavailability with injectable components creates flexible administration options not available in most peptide formulations
